Pfizer

UK study finds strong immune responses from one dose of Pfizer COVID-19 shot

One dose of Pfizer COVID-19 vaccine offers an immune response similar to that generated by infection and could also offer protection from variants to people who have previously had the…

Read More Here

EU export restrictions on COVID shots would be ‘lose-lose’ situation – Pfizer executive

European Union export restrictions on COVID-19 vaccines would result in a 'lose-lose' situation for everyone, including EU members, a Pfizer executive said, a day after the bloc tightened oversight of shot deliveries beyond its borders. The EU's action would give it greater scope to block shipments to…

Read More Here

EU’s Breton says Pfizer can help offset AstraZeneca vaccine delays

PARIS (Reuters) - The European Union will be able to stick to its vaccination targets this quarter despite AstraZeneca delivery delays as Pfizer is producing faster than planned, EU industry…

Read More Here

Pfizer vaccine production on the rise as pandemic hits one-year mark

Pfizer Inc and German partner BioNTech SE will exceed their original global production target for COVID-19 vaccines by as much as 20% this year, as they ramp up production a…

Read More Here

Pfizer, BioNTech can raise capacity to 3 billion COVID-19 vaccine doses next year

BioNTech SE could have capacity to make 3 billion doses of the COVID-19 vaccine it developed with partner Pfizer Inc next year, Bloomberg News reported, citing an interview with the…

Read More Here

U.S. administers 92.1 mln doses of COVID-19 vaccines

The United States has administered 92,089,852 doses of COVID-19 vaccines as of Monday morning and delivered 116,378,615 doses, the Centers for Disease Control and Prevention said. The tally of vaccine…

Read More Here

UK data show COVID vaccines work, scientists urge others to take note

British scientists urged European countries to take note of interim data showing what they described as “remarkable” effectiveness of a single dose of Pfizer’s or AstraZeneca’s COVID-19 vaccines in frail…

Read More Here

Pfizer vaccine may be less effective in people with obesity, says study

The Pfizer/BioNTech vaccine may be less effective in people with obesity, data suggests. Italian researchers have discovered that healthcare workers with obesity produced only about half the amount of antibodies…

Read More Here

Pfizer COVID-19 vaccine reduces transmission after one dose -UK study

A single dose of Pfizer and BioNtech's COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK…

Read More Here

‘Real-world’ UK data shows 70% decline in COVID infections after first Pfizer shot

England's coronavirus vaccine campaign is significantly reducing cases of COVID-19, with a drop of around 70% in infections among healthcare workers who have had a first dose of the Pfizer-BioNTech shot, British…

Read More Here

Pfizer seeks U.S. approval for COVID-19 vaccine to be stored at higher temperatures

FRANKFURT, Feb 19 (Reuters) - Pfizer Inc and BioNTech SE have asked the U.S. health regulator to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially…

Read More Here

Israeli study finds Pfizer vaccine 85% effective after first shot

The first dose of Pfizer Inc's COVID-19 vaccine is 85% effective, a study of healthcare workers at an Israeli hospital has found, potentially fuelling a debate over the recommended two-dose…

Read More Here

Pfizer plans to test COVID-19 vaccine booster engineered for South African variant

NEW YORK, Feb 18 (Reuters) - A top Pfizer Incscientist said on Thursday the company is in intensivediscussions with regulators to test a booster shot version ofits coronavirus vaccine specifically…

Read More Here

UPDATED: Researchers urge delay in administering Pfizer vaccine’s second dose, cite strong data

The second dose of Pfizer Inc's COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in…

Read More Here

Exclusive Pfizer’s COVID-19 vaccine supply to the EU 30% below plans, sources say

BRUSSELS, Feb 17 (Reuters) - Pfizer has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, EU officials said, leaving it…

Read More Here

North Korean hackers tried to steal Pfizer vaccine know-how, lawmaker says

South Korea's intelligence agency has said North Korea attempted to steal information on coronavirus vaccines and treatments by hacking Pfizer Inc, a lawmaker briefed by the agency said on Tuesday. Digital espionage targeting health bodies, vaccine scientists and drugmakers…

Read More Here

Pfizer says it could directly deliver COVID-19 vaccine to points of vaccination in South Africa

JOHANNESBURG, Feb 10 (Reuters) - Pfizer Inc said it could deliver its COVID-19 vaccine, which requires ultra-cold temperatures for storage and distribution, directly to points of vaccination in South Africa.…

Read More Here

INSIGHT-Vaccine vs variant

JERUSALEM, Feb 10 (Reuters) - Israel’s swift vaccination rollout has made it the largest real-world study of Pfizer Inc's COVID-19 vaccine. Results are trickling in, and they are promising. More…

Read More Here

EU finalises second deal with Pfizer for 300 mln vaccine doses

BRUSSELS, Feb 8 (Reuters) - The European Union has finalised a deal with Pfizer and BioNTech for the supply of an additional 300 million doses of their COVID-19 vaccine, a…

Read More Here

8.5% of US population gets Covid jab

The US Center for Disease Control and Prevention said it had administered 35,203,710 doses of COVID-19 vaccines in the country as of Thursday while 57,489,675 doses were distributed. This includes…

Read More Here

EU says Pfizer/BioNTech to deliver 75 million extra vaccine doses in second quarter

BRUSSELS, Feb 1 (Reuters) - Pfizer and German partner BioNTech will deliver 75 million extra doses of their COVID-19 vaccine in the second quarter of the year, European Commission President…

Read More Here

COVAX to send AstraZeneca shot to Latin America, some states to get Pfizer too

GENEVA, Feb 1 (Reuters) - The COVAX global vaccine sharing scheme expects to deliver 35.3 million doses of AstraZeneca's COVID-19 vaccine to 36 Caribbean and Latin American states from mid-February…

Read More Here

EMA – Gap between Pfizer doses should be three weeks

Amsterdam (dpa) - The European Medicines Agency (EMA) has tightened its guidelines for the use of the Pfizer/BioNTech vaccine in a resolution published on Thursday, according to which the second dose has to…

Read More Here

Canada to receive fewer Pfizer vaccine doses than expected in first quarter: media report

OTTAWA (Reuters) - Canada will receive only 3.5 million doses of Pfizer's COVID-19 vaccine in the first quarter of 2021, not the 4 million the country had expected, a reporter…

Read More Here

Italy asks EU to take action against Pfizer over COVID-19 vaccine delays

MILAN, Jan 26 (Reuters) - Italy asked the European Commission on Tuesday to take action against Pfizer over cuts to its COVID-19 vaccine deliveries, the government's special commissioner said. The…

Read More Here

Malta: Country orders 80,000 more Moderna vaccines as 14,000 Pfizer doses arrive

Malta is to spend €2 million to purchase an additional 80,000 doses of the Moderna COVID-19 vaccine, the prime minister said on Tuesday. Speaking in parliament, he also announced that…

Read More Here

Britain confident that vaccine makers will deliver for both UK and EU

Britain and the European Union should both get the vaccines they have ordered and it is wrong to respond to supply problems with restrictions, Nadhim Zahawi, the British COVID-19 vaccine deployment minister, said…

Read More Here

Italy sends warning letter to Pfizer over COVID vaccine delays

ROME, Jan 25 (Reuters) - The Italian government on Monday sent a letter of formal notice to Pfizer calling on the drug company to respect its contractual commitments over its…

Read More Here

Italy to take legal action over COVID vaccine delays to get promised doses

MILAN, Jan 24 (Reuters) - Italy will take legal action against Pfizer Inc and AstraZeneca over delays in deliveries of COVID-19 vaccines to secure agreed supplies rather than seek damages,…

Read More Here

UK doctors call for shorter gap between Pfizer vaccine doses

A group of British doctors have written to England's chief medical officer to tell him to cut the gap between doses of the Pfizer and BioNTech vaccine to six weeks…

Read More Here

Poland says it could take legal action over Pfizer COVID-19 vaccine delay

Poland could take legal action against Pfizer next month if the U.S. drugmaker does not deliver all scheduled doses of its COVID-19 vaccine, a government spokesman said on Friday. Pfizer,…

Read More Here

Norway says advice on use of Pfizer vaccine is unchanged

Norway said on Monday it was not changing its policy on the use of Pfizer and BioNTech's COVID-19 vaccine following reports of deaths in highly frail recipients after the inoculation…

Read More Here

U.S. COVID-19 vaccine supplies strain to meet wider eligibility, second doses

NEW YORK, Jan 16 (Reuters) - Scattered shortages of COVID-19 vaccines persisted on Saturday under pressure from growing demand, as previously inoculated Americans returned for their required second shots and…

Read More Here

Italy says Pfizer to cut vaccine supplies by 29% from Monday

MILAN, Jan 15 (Reuters) - U.S. drugs firm Pfizer has told Italy it will cut its deliveries of vaccine shots against the novel coronavirus by 29% starting from Monday, the country's COVID-19…

Read More Here

UPDATED: EU doubles COVID vaccine deal with Pfizer, EU countries cannot negotiate separate vaccine deals

The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the head of the European Commission said on Friday, in a…

Read More Here

UPDATED: EU in discussions with Pfizer-BioNTech for additional vaccine doses

The European Commission is in discussions with Pfizer and BioNTech about the possibility of ordering more doses of their COVID-19 vaccine, in addition to the 300 million shots already covered…

Read More Here

Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo

Pfizer Inc and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose of the vaccine…

Read More Here

EXPLAINER – How does AstraZeneca’s vaccine compare with Pfizer-BioNTech?

ZURICH, Dec 30 (Reuters) - Britain on Wednesday became the first country to approve AstraZeneca and Oxford University's home-grown UK COVID-19 vaccine, adding an easy-to-manage shot to the arsenal of…

Read More Here

Pfizer delayed delivery of new batch of vaccine to Spain by one day

MADRID (Reuters) - Pfizer has postponed the delivery of a new batch of the coronavirus vaccine to Spain by one day to Tuesday due to a logistics hurdle, Health Minister…

Read More Here

Italy approves Pfizer vaccine, France to approve it on December 24

PARIS (Reuters) - French medical regulator HAS said on Tuesday it would decide on Dec. 24 whether to approve the vaccine developed by Pfizer and BioNTech for France's vaccination rollout,…

Read More Here

UPDATED: EU agreed to pay 15.5 euros per dose for Pfizer COVID-19 vaccine

The European Union has agreed to pay 15.50 euros ($18.90) per dose for the COVID-19 vaccine developed by Pfizer and BioNTech, an internal EU document reviewed by Reuters shows. The…

Read More Here

European Medicines Agency to review Pfizer COVID-19 vaccine

Europe's medicines regulator will on Monday assess the COVID-19 vaccine jointly developed by U.S. company Pfizer and its German partner BioNTech , with a green light to put Europe on…

Read More Here

How the Moderna vaccine stacks up against Pfizer/BioNTech’s

U.S. regulators authorized Moderna Inc’s COVID-19 vaccine for emergency use on Friday, a week after granting the first U.S. authorization to Pfizer Inc and BioNTech SE’s coronavirus shot. The following…

Read More Here

U.S. investigating 5 allergic reactions from Pfizer shot

The U.S. Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE's COVID-19 vaccine in the United States this…

Read More Here

EU to order more Pfizer vaccine after declining earlier offer

BRUSSELS, Dec 17 (Reuters) - The European Union will take up its option to buy up to 100 million more doses of Pfizer and BioNTech's COVID-19 vaccine after turning down…

Read More Here

Britain gets ready for roll-out of Pfizer’s COVID-19 vaccine this week

LONDON, Dec 6 (Reuters) - Britain is preparing to become the first country to roll out the Pfizer/BioNTech COVID-19 vaccine this week, initially making the shot available at hospitals before…

Read More Here

Pfizer halves vaccine supply estimate

US pharma giant Pfizer has said that it will deliver 50 million doses this year of its COVID-19 vaccine, which was developed by German firm BioNTech. The new forecast represents…

Read More Here

Fauci apologises for casting doubt over UK’s approval of Pfizer vaccine

LONDON (Reuters) - Anthony Fauci, the top U.S. infectious diseases expert, apologised on Thursday after casting doubt over the rigour of the British regulators who approved the Pfizer vaccine against…

Read More Here

Pfizer says supply chain challenges contributed to slashed target for COVID-19 vaccine doses in 2020

Challenges in Pfizer Inc's supply chain for the raw materials used in its COVID-19 vaccine played a role in its decision to slash its 2020 production target, a Pfizer spokeswoman…

Read More Here

Pfizer files COVID-19 vaccine application to U.S. FDA

Pfizer Inc applied to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against…

Read More Here

Britain asks regulator to assess Pfizer vaccine for suitability

Britain has formally asked its medical regulator, the MHRA, to assess the COVID-19 vaccine being produced by Pfizer Inc and its German partner BioNTech, health minister Matt Hancock said on…

Read More Here

BioNTech says vaccine approval possible in mid-December under ideal conditions

U.S. and European regulators could approve Pfizer and BioNTech's experimental COVID-19 vaccine as early as mid-December, the German firm's chief executive said, following the release of positive trial results. Speaking…

Read More Here

UPDATED: Pfizer to seek emergency-use authorization for Covid vaccine

Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply…

Read More Here

Scientist behind BioNTech/Pfizer vaccine says it can end pandemic

The scientist behind the first Covid-19 vaccine to clear interim clinical trials says he is confident his product can “bash the virus over the head” and put an end to…

Read More Here

Israel signs deal with Pfizer for potential COVID-19 vaccine

Israel has signed a deal with Pfizer Inc to receive the drugmaker's potential COVID-19 vaccine, Prime Minister Benjamin Netanyahu said on Friday. Pfizer and its partner BioNTech SE confirmed a…

Read More Here

‘It seems too early’ – in Europe, safety concerns dampen excitement over COVID-19 vaccine

Some Europeans on Tuesday injected a dose of caution into the excitement which greeted news that Pfizer's experimental COVID-19 vaccine was more than 90% effective in initial trials, expressing doubts…

Read More Here

Pfizer COVID-19 vaccine ‘very promising’ but has cold chain issues – WHO

The World Health Organization's (WHO) chief said on Tuesday it hopes to have a COVID-19 vaccine by year-end and that Pfizer's experimental remedy is "a very promising one", with more…

Read More Here